![Yi Shan Li](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yi Shan Li
Founder at
BLOSSOMHILL THERAPEUTICS, INC.
Profile
Yi Shan Li is the founder of Blossomhill Therapeutics, Inc., founded in 2020, holding the title of Executive Chairman since 2020.
Dr. Li was the founder of Turning Point Therapeutics, Inc., founded in 2013, and held the title Head-TP Therapeutics Asia in 2019.
Former jobs include Director at SABiosciences Corp.
from 2002 to 2009, Executive Vice President at Epitomics, Inc. from 2008 to 2013, Member at the University of California, Berkeley, Principal at RBC Capital Markets LLC, Vice President at Kenson Ventures LLC from 2001 to 2003, and Principal at Santa Cruz Biotechnology, Inc. Education history includes a doctorate from The Ohio State University in 1994, an undergraduate degree from the University of Science & Technology of China in 1987, and an MBA from Haas School of Business in 2001.
Yi Shan Li active positions
| Companies | Position | Start |
|---|---|---|
| BLOSSOMHILL THERAPEUTICS, INC. | Founder | 2020-05-31 |
Former positions of Yi Shan Li
| Companies | Position | End |
|---|---|---|
| TURG POIN | Chief Executive Officer | 2018-08-31 |
Epitomics, Inc.
 Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody technology used for research and diagnostics | Corporate Officer/Principal | 2013-04-29 |
SABiosciences Corp.
 SABiosciences Corp. Medical SpecialtiesHealth Technology Develops and markets technologies for genetic and medical research | Director/Board Member | 2009-12-30 |
Kenson Ventures LLC
 Kenson Ventures LLC Investment ManagersFinance Kenson Ventures invests in companies located in the United States with an investment size from USD 0.5 - 3 million. The firm focuses on sectors such as biotechnology and life sciences. It participates in early and late-stage transactions. It also takes a seat on the board of directors. | Private Equity Investor | 2003-12-30 |
RBC Capital Markets LLC
 RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Education of Yi Shan Li
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
92
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Epitomics, Inc.
Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody technology used for research and diagnostics | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Kenson Ventures LLC
Kenson Ventures LLC Investment ManagersFinance Kenson Ventures invests in companies located in the United States with an investment size from USD 0.5 - 3 million. The firm focuses on sectors such as biotechnology and life sciences. It participates in early and late-stage transactions. It also takes a seat on the board of directors. | Finance |
Santa Cruz Biotechnology, Inc.
 Santa Cruz Biotechnology, Inc. BiotechnologyHealth Technology Provides primary antibodies and support products services | Health Technology |
University of Science & Technology of China
 University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SABiosciences Corp.
SABiosciences Corp. Medical SpecialtiesHealth Technology Develops and markets technologies for genetic and medical research | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Yi Shan Li
